The purpose of the company is to provide services for the development of manufacturing processes for injectable pharmaceuticals and therapies. The company may grant direct or indirect financing to its direct or indirect subsidiaries and third parties, including its direct or indirect shareholders and their direct or indirect subsidiaries, for its own liabilities and those of other companies (including direct or indirect shareholders of the company and companies in which these shareholders are involved), provide securities of all kinds, including by way of pledges or fiduciary transfers or assignments of the company's assets, or provide guarantees, enter into sureties or otherwise secure or guarantee the obligations of these other companies, whether for consideration or not, and even if such financing or security transactions are in the exclusive interest of another company. Furthermore, it may engage in liquidity balancing/concentration of net liquidity (cash pooling) with the aforementioned companies or join such a system, including periodic account balancing. This also applies to preferential conditions without interest, excluding the company's profitability and assuming cluster risks. The company may buy, rent and sell real estate, participate in other companies, acquire and exploit industrial property rights and know-how, and carry out all activities that are beneficial to the company or are directly or indirectly related to it.
Outbound Leads by COHAGA